{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:24:46Z","timestamp":1787498686416,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T00:00:00Z","timestamp":1739664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T00:00:00Z","timestamp":1739664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["No. JCYJ20220530150812027"],"award-info":[{"award-number":["No. JCYJ20220530150812027"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["No. JCYJ20220531094207017"],"award-info":[{"award-number":["No. JCYJ20220531094207017"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["No. JCYJ20220531094217040"],"award-info":[{"award-number":["No. JCYJ20220531094217040"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzen Municipality","doi-asserted-by":"publisher","award":["No. SZSM202111007"],"award-info":[{"award-number":["No. SZSM202111007"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Biol Lett"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Recent studies have illuminated the complexities of treating advanced bladder cancer (BCa), underscoring the importance of comprehending its molecular mechanisms for creating novel therapies. While the role of Karyopherin a2 (\n                      <jats:italic>KPNA2<\/jats:italic>\n                      ) in promoting BCa growth is established, the precise mechanism remains elusive.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      To investigate the regulatory role of\n                      <jats:italic>KPNA2<\/jats:italic>\n                      in BCa, we employed a comprehensive approach integrating clinical case data and bioinformatics analysis to evaluate the expression of\n                      <jats:italic>KPNA2<\/jats:italic>\n                      in BCa tissues. Mechanisms promoting cancer by\n                      <jats:italic>KPNA2<\/jats:italic>\n                      were examined using both in vivo and in vitro models.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Our research reveals that miR-26b-5p acts as an anticancer factor by targeting and inhibiting\n                      <jats:italic>KPNA2<\/jats:italic>\n                      expression. Furthermore, we have observed that the interaction between\n                      <jats:italic>KPNA2<\/jats:italic>\n                      and Kinesin Family Member C1 (\n                      <jats:italic>KIFC1<\/jats:italic>\n                      ) facilitates the transition of BCa cells into the G2\/M phase, thereby promoting tumor advancement via activation of the Phosphoinositide 3-kinase (PI3K)- Protein Kinase B (AKT) pathway. Importantly, this investigation is the first to identify\n                      <jats:italic>KPNA2<\/jats:italic>\n                      expression in exosomes originating from BCa tissues. Plasma exosomes from patients with BCa exhibited notably increased levels of\n                      <jats:italic>KPNA2<\/jats:italic>\n                      compared with healthy controls, suggesting\n                      <jats:italic>KPNA2<\/jats:italic>\n                      as a potential new tumor indicator. Additionally,\n                      <jats:italic>KPNA2<\/jats:italic>\n                      from BCa cells triggered the conversion of fibroblasts into cancer-associated fibroblasts (CAFs), which secreted elevated levels of interleukin-6 (IL-6), contributing to a tumor-supporting environment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      These findings suggest that\n                      <jats:italic>KPNA2<\/jats:italic>\n                      is a key gene that promotes BCa progression, can potentially be a novel tumor marker, and may serve as a new therapeutic target for BCa.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s11658-025-00687-w","type":"journal-article","created":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T05:13:11Z","timestamp":1739682791000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Tumor-derived exosomal KPNA2 activates fibroblasts and interacts with KIFC1 to promote bladder cancer progression, a process inhibited by miR-26b-5p"],"prefix":"10.1186","volume":"30","author":[{"given":"Cong","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cen","family":"Liufu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bentao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,16]]},"reference":[{"issue":"3","key":"687_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"687_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrc3817","volume":"15","author":"MA Knowles","year":"2015","unstructured":"Knowles MA, Hurst CD. Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity. Nat Rev Cancer. 2015;15(1):25\u201341.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"687_CR3","doi-asserted-by":"publisher","first-page":"237","DOI":"10.7150\/thno.21945","volume":"8","author":"C He","year":"2018","unstructured":"He C, Zheng S, Luo Y, Wang B. Exosome theranostics: biology and translational medicine. Theranostics. 2018;8(1):237\u201355.","journal-title":"Theranostics"},{"issue":"1","key":"687_CR4","doi-asserted-by":"publisher","first-page":"1887552","DOI":"10.1080\/2162402X.2021.1887552","volume":"10","author":"C Han","year":"2021","unstructured":"Han C, Zhang C, Wang H, Zhao L. Exosome-mediated communication between tumor cells and tumor-associated macrophages: implications for tumor microenvironment. Oncoimmunology. 2021;10(1):1887552.","journal-title":"Oncoimmunology"},{"issue":"1","key":"687_CR5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13045-017-0542-8","volume":"10","author":"A Li","year":"2017","unstructured":"Li A, Zhang T, Zheng M, Liu Y, Chen Z. Exosomal proteins as potential markers of tumor diagnosis. J Hematol Oncol. 2017;10(1):175.","journal-title":"J Hematol Oncol"},{"key":"687_CR6","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1186\/s12885-015-1369-8","volume":"15","author":"B Shi","year":"2015","unstructured":"Shi B, Su B, Fang D, Tang Y, Xiong G, Guo Z, et al. High expression of KPNA2 defines poor prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. BMC Cancer. 2015;15:380.","journal-title":"BMC Cancer"},{"key":"687_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.902220","volume":"9","author":"Z Wei","year":"2022","unstructured":"Wei Z, Xu J, Li W, Ou L, Zhou Y, Wang Y, et al. SMARCC1 enters the nucleus via KPNA2 and plays an oncogenic role in bladder cancer. Front Mol Biosci. 2022;9: 902220.","journal-title":"Front Mol Biosci"},{"issue":"45","key":"687_CR8","doi-asserted-by":"publisher","first-page":"72767","DOI":"10.18632\/oncotarget.11889","volume":"7","author":"J Zhou","year":"2016","unstructured":"Zhou J, Dong D, Cheng R, Wang Y, Jiang S, Zhu Y, et al. Aberrant expression of KPNA2 is associated with a poor prognosis and contributes to OCT4 nuclear transportation in bladder cancer. Oncotarget. 2016;7(45):72767\u201376.","journal-title":"Oncotarget"},{"key":"687_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2021.104955","volume":"139","author":"Y Sun","year":"2021","unstructured":"Sun Y, Li W, Li X, Zheng H, Qiu Y, Yang H. Oncogenic role of karyopherin \u03b12 (KPNA2) in human tumors: a pan-cancer analysis. Comput Biol Med. 2021;139: 104955.","journal-title":"Comput Biol Med"},{"issue":"1","key":"687_CR10","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12943-022-01658-x","volume":"21","author":"Z Pan","year":"2022","unstructured":"Pan Z, Xu T, Bao L, Hu X, Jin T, Chen J, et al. CREB3L1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by remodeling the tumor microenvironment. Mol Cancer. 2022;21(1):190.","journal-title":"Mol Cancer"},{"issue":"8","key":"687_CR11","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.cell.2023.03.016","volume":"186","author":"Y Chhabra","year":"2023","unstructured":"Chhabra Y, Weeraratna AT. Fibroblasts in cancer: unity in heterogeneity. Cell. 2023;186(8):1580\u2013609.","journal-title":"Cell"},{"issue":"4","key":"687_CR12","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/ijc.32193","volume":"146","author":"M Nurmik","year":"2020","unstructured":"Nurmik M, Ullmann P, Rodriguez F, Haan S, Letellier E. In search of definitions: cancer-associated fibroblasts and their markers. Int J Cancer. 2020;146(4):895\u2013905.","journal-title":"Int J Cancer"},{"issue":"10","key":"687_CR13","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1002\/ijc.25568","volume":"128","author":"CI Wang","year":"2011","unstructured":"Wang CI, Wang CL, Wang CW, Chen CD, Wu CC, Liang Y, et al. Importin subunit alpha-2 is identified as a potential biomarker for non-small cell lung cancer by integration of the cancer cell secretome and tissue transcriptome. Int J Cancer. 2011;128(10):2364\u201372.","journal-title":"Int J Cancer"},{"issue":"4","key":"687_CR14","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.3892\/or.2014.3381","volume":"32","author":"S Ma","year":"2014","unstructured":"Ma S, Zhao X. KPNA2 is a promising biomarker candidate for esophageal squamous cell carcinoma and correlates with cell proliferation. Oncol Rep. 2014;32(4):1631\u20137.","journal-title":"Oncol Rep"},{"issue":"5543","key":"687_CR15","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1126\/science.1064921","volume":"294","author":"M Lagos-Quintana","year":"2001","unstructured":"Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science. 2001;294(5543):853\u20138.","journal-title":"Science"},{"issue":"7027","key":"687_CR16","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nature03315","volume":"433","author":"LP Lim","year":"2005","unstructured":"Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature. 2005;433(7027):769\u201373.","journal-title":"Nature"},{"issue":"1","key":"687_CR17","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1101\/gr.082701.108","volume":"19","author":"RC Friedman","year":"2009","unstructured":"Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19(1):92\u2013105.","journal-title":"Genome Res"},{"issue":"9","key":"687_CR18","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1111\/cas.14126","volume":"110","author":"KH Xiao","year":"2019","unstructured":"Xiao KH, Teng K, Ye YL, Tan L, Chen MK, Liang HT, et al. Kinesin family member C1 accelerates bladder cancer cell proliferation and induces epithelial-mesenchymal transition via Akt\/GSK3\u03b2 signaling. Cancer Sci. 2019;110(9):2822\u201333.","journal-title":"Cancer Sci"},{"issue":"2","key":"687_CR19","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ctrv.2003.07.007","volume":"30","author":"JA Fresno Vara","year":"2004","unstructured":"Fresno Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C, Gonz\u00e1lez-Bar\u00f3n M. PI3K\/Akt signalling pathway and cancer. Cancer Treat Rev. 2004;30(2):193\u2013204.","journal-title":"Cancer Treat Rev"},{"key":"687_CR20","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.gene.2019.02.076","volume":"698","author":"S Noorolyai","year":"2019","unstructured":"Noorolyai S, Shajari N, Baghbani E, Sadreddini S, Baradaran B. The relation between PI3K\/AKT signalling pathway and cancer. Gene. 2019;698:120\u20138.","journal-title":"Gene"},{"key":"687_CR21","doi-asserted-by":"publisher","first-page":"6478","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367:6478.","journal-title":"Science"},{"issue":"2","key":"687_CR22","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.bbcan.2019.04.004","volume":"1871","author":"L Zhang","year":"2019","unstructured":"Zhang L, Yu D. Exosomes in cancer development, metastasis, and immunity. Biochim Biophys Acta Rev Cancer. 2019;1871(2):455\u201368.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"687_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12943-022-01509-9","volume":"21","author":"D Yu","year":"2022","unstructured":"Yu D, Li Y, Wang M, Gu J, Xu W, Cai H, et al. Exosomes as a new frontier of cancer liquid biopsy. Mol Cancer. 2022;21(1):56.","journal-title":"Mol Cancer"},{"issue":"1","key":"687_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13045-022-01305-4","volume":"15","author":"MDA Paskeh","year":"2022","unstructured":"Paskeh MDA, Entezari M, Mirzaei S, Zabolian A, Saleki H, Naghdi MJ, et al. Emerging role of exosomes in cancer progression and tumor microenvironment remodeling. J Hematol Oncol. 2022;15(1):83.","journal-title":"J Hematol Oncol"},{"key":"687_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.smim.2017.12.003","volume":"35","author":"TL Whiteside","year":"2018","unstructured":"Whiteside TL. Exosome and mesenchymal stem cell cross-talk in the tumor microenvironment. Semin Immunol. 2018;35:69\u201379.","journal-title":"Semin Immunol"},{"issue":"1","key":"687_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12885-019-5353-6","volume":"19","author":"CR Goulet","year":"2019","unstructured":"Goulet CR, Champagne A, Bernard G, Vandal D, Chabaud S, Pouliot F, et al. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling. BMC Cancer. 2019;19(1):137.","journal-title":"BMC Cancer"},{"issue":"9","key":"687_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e19802","volume":"9","author":"L Huang","year":"2023","unstructured":"Huang L, Xie Q, Deng J, Wei WF. The role of cancer-associated fibroblasts in bladder cancer progression. Heliyon. 2023;9(9): e19802.","journal-title":"Heliyon"},{"issue":"3","key":"687_CR28","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1097\/CAD.0000000000001268","volume":"33","author":"Q Du","year":"2022","unstructured":"Du Q, Yuan Z, Huang X, Huang Y, Zhang J, Li R. miR-26b-5p suppresses chemoresistance in breast cancer by targeting serglycin. Anticancer Drugs. 2022;33(3):308\u201319.","journal-title":"Anticancer Drugs"},{"issue":"9","key":"687_CR29","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.prp.2018.07.025","volume":"214","author":"CM Jia","year":"2018","unstructured":"Jia CM, Tian YY, Quan LN, Jiang L, Liu AC. miR-26b-5p suppresses proliferation and promotes apoptosis in multiple myeloma cells by targeting JAG1. Pathol Res Pract. 2018;214(9):1388\u201394.","journal-title":"Pathol Res Pract"},{"issue":"1","key":"687_CR30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s11658-021-00288-3","volume":"26","author":"S Ma","year":"2021","unstructured":"Ma S, Wei H, Wang C, Han J, Chen X, Li Y. MiR-26b-5p inhibits cell proliferation and EMT by targeting MYCBP in triple-negative breast cancer. Cell Mol Biol Lett. 2021;26(1):52.","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"687_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12967-023-03933-x","volume":"21","author":"T Xu","year":"2023","unstructured":"Xu T, Xie M, Jing X, Jiang H, Wu X, Wang X, et al. Loss of miR-26b-5p promotes gastric cancer progression via miR-26b-5p-PDE4B\/CDK8-STAT3 feedback loop. J Transl Med. 2023;21(1):77.","journal-title":"J Transl Med"},{"key":"687_CR32","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2147\/OTT.S236319","volume":"13","author":"A Zhou","year":"2020","unstructured":"Zhou A, Pan H, Sun D, Xu H, Zhang C, Chen X, et al. miR-26b-5p inhibits the proliferation, migration and invasion of human papillary thyroid cancer in a \u03b2-catenin-dependent manner. Onco Targets Ther. 2020;13:1593\u2013603.","journal-title":"Onco Targets Ther"},{"issue":"14","key":"687_CR33","doi-asserted-by":"publisher","first-page":"7730","DOI":"10.1111\/jcmm.15402","volume":"24","author":"F Han","year":"2020","unstructured":"Han F, Huang D, Huang X, Wang W, Yang S, Chen S. Exosomal microRNA-26b-5p down-regulates ATF2 to enhance radiosensitivity of lung adenocarcinoma cells. J Cell Mol Med. 2020;24(14):7730\u201342.","journal-title":"J Cell Mol Med"},{"issue":"12","key":"687_CR34","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1016\/j.febslet.2014.04.044","volume":"588","author":"T Wu","year":"2014","unstructured":"Wu T, Chen W, Liu S, Lu H, Wang H, Kong D, et al. Huaier suppresses proliferation and induces apoptosis in human pulmonary cancer cells via upregulation of miR-26b-5p. FEBS Lett. 2014;588(12):2107\u201314.","journal-title":"FEBS Lett"},{"key":"687_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.144989","volume":"760","author":"A Parvin","year":"2020","unstructured":"Parvin A, Hao SL, Tan FQ, Yang WX. Inhibition of kinesin motor protein KIFC1 by AZ82 induces multipolar mitosis and apoptosis in prostate cancer cell. Gene. 2020;760: 144989.","journal-title":"Gene"},{"issue":"5","key":"687_CR36","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/s41418-023-01140-1","volume":"30","author":"O Saatci","year":"2023","unstructured":"Saatci O, Akbulut O, Cetin M, Sikirzhytski V, Uner M, Lengerli D, et al. Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification. Cell Death Differ. 2023;30(5):1305\u201319.","journal-title":"Cell Death Differ"},{"issue":"14","key":"687_CR37","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.4161\/cc.29279","volume":"13","author":"M May","year":"2014","unstructured":"May M, Schelle I, Brakebusch C, Rottner K, Genth H. Rac1-dependent recruitment of PAK2 to G2 phase centrosomes and their roles in the regulation of mitotic entry. Cell Cycle. 2014;13(14):2211\u201321.","journal-title":"Cell Cycle"},{"issue":"6117","key":"687_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/327031a0","volume":"327","author":"MG Lee","year":"1987","unstructured":"Lee MG, Nurse P. Complementation used to clone a human homologue of the fission yeast cell cycle control gene cdc2. Nature. 1987;327(6117):31\u20135.","journal-title":"Nature"},{"key":"687_CR39","doi-asserted-by":"publisher","first-page":"6917","DOI":"10.2147\/IJN.S264498","volume":"15","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Bi J, Huang J, Tang Y, Du S, Li P. Exosome: a review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications. Int J Nanomedicine. 2020;15:6917\u201334.","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"687_CR40","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41392-020-00261-0","volume":"5","author":"J Dai","year":"2020","unstructured":"Dai J, Su Y, Zhong S, Cong L, Liu B, Yang J, et al. Exosomes: key players in cancer and potential therapeutic strategy. Signal Transduct Target Ther. 2020;5(1):145.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"687_CR41","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1172\/JCI81129","volume":"126","author":"R Xu","year":"2016","unstructured":"Xu R, Greening DW, Zhu HJ, Takahashi N, Simpson RJ. Extracellular vesicle isolation and characterization: toward clinical application. J Clin Invest. 2016;126(4):1152\u201362.","journal-title":"J Clin Invest"},{"issue":"1","key":"687_CR42","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s41467-017-02583-0","volume":"9","author":"T Fang","year":"2018","unstructured":"Fang T, Lv H, Lv G, Li T, Wang C, Han Q, et al. Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer. Nat Commun. 2018;9(1):191.","journal-title":"Nat Commun"},{"issue":"1","key":"687_CR43","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12943-023-01824-9","volume":"22","author":"T He","year":"2023","unstructured":"He T, Zhang Q, Xu P, Tao W, Lin F, Liu R, et al. Extracellular vesicle-circEHD2 promotes the progression of renal cell carcinoma by activating cancer-associated fibroblasts. Mol Cancer. 2023;22(1):117.","journal-title":"Mol Cancer"},{"issue":"8","key":"687_CR44","doi-asserted-by":"publisher","first-page":"7282","DOI":"10.18632\/aging.103076","volume":"12","author":"K Yao","year":"2020","unstructured":"Yao K, He L, Gan Y, Liu J, Tang J, Long Z, et al. HMGN5 promotes IL-6-induced epithelial-mesenchymal transition of bladder cancer by interacting with Hsp27. Aging (Albany NY). 2020;12(8):7282\u201398.","journal-title":"Aging (Albany NY)"}],"container-title":["Cellular &amp; Molecular Biology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-025-00687-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11658-025-00687-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-025-00687-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T05:13:14Z","timestamp":1739682794000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmbl.biomedcentral.com\/articles\/10.1186\/s11658-025-00687-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,16]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["687"],"URL":"https:\/\/doi.org\/10.1186\/s11658-025-00687-w","relation":{},"ISSN":["1689-1392"],"issn-type":[{"value":"1689-1392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,16]]},"assertion":[{"value":"9 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was obtained from the Human and Animal Research Ethics Committee of the First Affiliated Hospital of Shenzhen University (Shenzhen, China) (No. 2024SYY-010, Date of approval: 18 April 2024). Animal experiments were approved by the Animal Ethics Committee of the First Affiliated Hospital of Shenzhen University (Shenzhen, China) (no. 20240060, Date of approval: 15 April 2024). The ethics committee of the First Affiliated Hospital of Shenzhen University follows the provisions of the Declaration of Helsinki and the Basel Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read the manuscript and provided their consent for the submission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}